CCNE1 and breast cancer: Given the fact that PPARγ has been reported to act as a tumor suppressor in several cancers and PPARγ silencing increased the expression of C-myc, NF-κB, CyclinD1, cyclin E, MMP2, and MMP9 in BC cells [28, 29].